Catalyst Pharmaceutical
CPRX
CPRX
367 hedge funds and large institutions have $2.39B invested in Catalyst Pharmaceutical in 2025 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 126 increasing their positions, 122 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 334 → 367 (+33)
3% more repeat investments, than reductions
Existing positions increased: 126 | Existing positions reduced: 122
0.88% less ownership
Funds ownership: 81.77% → 80.89% (-0.88%)
Holders
367
Holding in Top 10
6
Calls
$2.48M
Puts
$547K
Top Buyers
| 1 | +$52.2M | |
| 2 | +$15.9M | |
| 3 | +$14.9M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$13.5M |
| 5 |
NVCHI
New Vernon Capital Holdings II
Morristown,
New Jersey
|
+$13.3M |
Top Sellers
| 1 | -$51M | |
| 2 | -$48.3M | |
| 3 | -$20M | |
| 4 |
BlackRock
New York
|
-$15.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.2M |
